Research Library › Editorial standards
The Kalibra Research Desk publishes neutral, cited reference pages and news on research peptides: what each compound is, where it came from, what has been studied, how strong that evidence is, and where regulators stand. This page sets out the rules every page and post follows.
What we publish
- Compound reference pages: origin, structure, research history and regulatory status for every compound in Kalibra’s supplier catalogs, including compounds Kalibra does not sell, which are marked as reference only.
- Research Pulse: a regular round-up of new papers, clinical-trial updates and development news.
- Regulatory updates: FDA approvals, compounding-list changes, advisory committee votes, warning letters and anti-doping list changes, tracked on the FDA Peptide Regulatory Tracker.
- Science explainers: how peptides are made and tested, how to read a study, and how to read a Certificate of Analysis.
What we never publish
- Dosing, amounts, schedules, reconstitution or administration instructions for people or animals.
- Claims that any compound treats, prevents or improves any condition, or “results”, testimonials or before-and-after content.
- Copies of other publishers’ articles. We summarize in our own words and link to the original.
- Paid placements or sponsored claims.
How we source
Every factual statement is cited with a numbered reference. We prefer primary sources: peer-reviewed papers (PubMed, DOI), regulator documents (FDA, EMA and other national agencies), ClinicalTrials.gov registrations, patents and company filings. We do not cite vendor sites, forums or social media as evidence. Where a fact cannot be confirmed in a primary source, we leave it out.
How we describe evidence
We say plainly what kind of evidence exists: laboratory (in vitro) work, animal studies, or controlled human trials. Findings from cells or animals are never presented as effects in people. Results that come mainly from one research group, or that have attracted expressions of concern or retractions, are labeled as such.
Dates, updates and corrections
Every page carries the date its regulatory information was last checked. Regulatory pages are reviewed when the FDA or another regulator publishes a change. If you find an error, email support@kalibralabs.com with the page and the source; confirmed corrections are made promptly and noted on the page.
Independence
Kalibra Labs LLC sells research materials, and that is disclosed here and on every page. Reference coverage does not depend on whether Kalibra sells a compound, and pages do not promote products.
The Kalibra Research Desk reports on published research and regulatory actions. It does not give medical, dosing or usage advice, and nothing here describes use in people or animals. Kalibra Labs products are for laboratory research use only.
